vs

Side-by-side financial comparison of DONEGAL GROUP INC (DGICA) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

DONEGAL GROUP INC is the larger business by last-quarter revenue ($236.0M vs $197.9M, roughly 1.2× REPLIGEN CORP). REPLIGEN CORP runs the higher net margin — 6.7% vs 4.9%, a 1.8% gap on every dollar of revenue. On growth, REPLIGEN CORP posted the faster year-over-year revenue change (13.6% vs -3.7%). Over the past eight quarters, REPLIGEN CORP's revenue compounded faster (14.4% CAGR vs -2.2%).

Donegal Group Inc. is a regional US insurance holding company offering personal and commercial property and casualty insurance products. It serves Mid-Atlantic, Midwest, and Southern US customers, delivering tailored coverage for individuals, families, and small to medium businesses.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

DGICA vs RGEN — Head-to-Head

Bigger by revenue
DGICA
DGICA
1.2× larger
DGICA
$236.0M
$197.9M
RGEN
Growing faster (revenue YoY)
RGEN
RGEN
+17.4% gap
RGEN
13.6%
-3.7%
DGICA
Higher net margin
RGEN
RGEN
1.8% more per $
RGEN
6.7%
4.9%
DGICA
Faster 2-yr revenue CAGR
RGEN
RGEN
Annualised
RGEN
14.4%
-2.2%
DGICA

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
DGICA
DGICA
RGEN
RGEN
Revenue
$236.0M
$197.9M
Net Profit
$11.5M
$13.3M
Gross Margin
52.5%
Operating Margin
9.0%
Net Margin
4.9%
6.7%
Revenue YoY
-3.7%
13.6%
Net Profit YoY
-54.3%
143.9%
EPS (diluted)
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DGICA
DGICA
RGEN
RGEN
Q1 26
$236.0M
Q4 25
$239.8M
$197.9M
Q3 25
$245.9M
$188.8M
Q2 25
$247.1M
$182.4M
Q1 25
$245.2M
$169.2M
Q4 24
$250.0M
$174.1M
Q3 24
$251.7M
$154.9M
Q2 24
$246.8M
$154.1M
Net Profit
DGICA
DGICA
RGEN
RGEN
Q1 26
$11.5M
Q4 25
$17.2M
$13.3M
Q3 25
$20.1M
$14.9M
Q2 25
$16.9M
$14.9M
Q1 25
$25.2M
$5.8M
Q4 24
$24.0M
$-30.3M
Q3 24
$16.8M
$-654.0K
Q2 24
$4.2M
$3.3M
Gross Margin
DGICA
DGICA
RGEN
RGEN
Q1 26
Q4 25
52.5%
Q3 25
53.2%
Q2 25
50.0%
Q1 25
53.6%
Q4 24
26.1%
Q3 24
50.0%
Q2 24
49.8%
Operating Margin
DGICA
DGICA
RGEN
RGEN
Q1 26
Q4 25
8.7%
9.0%
Q3 25
10.2%
8.9%
Q2 25
8.3%
7.6%
Q1 25
12.7%
3.9%
Q4 24
11.9%
-17.7%
Q3 24
8.1%
-5.1%
Q2 24
2.0%
1.0%
Net Margin
DGICA
DGICA
RGEN
RGEN
Q1 26
4.9%
Q4 25
7.2%
6.7%
Q3 25
8.2%
7.9%
Q2 25
6.8%
8.2%
Q1 25
10.3%
3.4%
Q4 24
9.6%
-17.4%
Q3 24
6.7%
-0.4%
Q2 24
1.7%
2.2%
EPS (diluted)
DGICA
DGICA
RGEN
RGEN
Q1 26
Q4 25
$0.24
Q3 25
$0.26
Q2 25
$0.26
Q1 25
$0.10
Q4 24
$-0.55
Q3 24
$-0.01
Q2 24
$0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DGICA
DGICA
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$767.6M
Total DebtLower is stronger
$542.2M
Stockholders' EquityBook value
$649.1M
$2.1B
Total Assets
$2.4B
$2.9B
Debt / EquityLower = less leverage
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DGICA
DGICA
RGEN
RGEN
Q1 26
Q4 25
$767.6M
Q3 25
$748.7M
Q2 25
$708.9M
Q1 25
$697.2M
Q4 24
$757.4M
Q3 24
$784.0M
Q2 24
$809.1M
Total Debt
DGICA
DGICA
RGEN
RGEN
Q1 26
Q4 25
$542.2M
Q3 25
$537.9M
Q2 25
Q1 25
Q4 24
$525.6M
Q3 24
Q2 24
Stockholders' Equity
DGICA
DGICA
RGEN
RGEN
Q1 26
$649.1M
Q4 25
$640.4M
$2.1B
Q3 25
$627.4M
$2.1B
Q2 25
$605.7M
$2.1B
Q1 25
$584.7M
$2.0B
Q4 24
$545.8M
$2.0B
Q3 24
$513.4M
$2.0B
Q2 24
$484.1M
$2.0B
Total Assets
DGICA
DGICA
RGEN
RGEN
Q1 26
$2.4B
Q4 25
$2.4B
$2.9B
Q3 25
$2.4B
$2.9B
Q2 25
$2.4B
$2.9B
Q1 25
$2.4B
$2.9B
Q4 24
$2.3B
$2.8B
Q3 24
$2.3B
$2.8B
Q2 24
$2.3B
$2.9B
Debt / Equity
DGICA
DGICA
RGEN
RGEN
Q1 26
Q4 25
0.26×
Q3 25
0.26×
Q2 25
Q1 25
Q4 24
0.27×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DGICA
DGICA
RGEN
RGEN
Operating Cash FlowLast quarter
$25.7M
Free Cash FlowOCF − Capex
$17.6M
FCF MarginFCF / Revenue
8.9%
Capex IntensityCapex / Revenue
4.1%
Cash ConversionOCF / Net Profit
1.93×
TTM Free Cash FlowTrailing 4 quarters
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DGICA
DGICA
RGEN
RGEN
Q1 26
Q4 25
$70.2M
$25.7M
Q3 25
$22.4M
$48.1M
Q2 25
$12.1M
$28.6M
Q1 25
$25.7M
$15.0M
Q4 24
$67.4M
$39.2M
Q3 24
$12.7M
$49.3M
Q2 24
$21.7M
$42.2M
Free Cash Flow
DGICA
DGICA
RGEN
RGEN
Q1 26
Q4 25
$17.6M
Q3 25
$43.4M
Q2 25
$21.5M
Q1 25
$11.4M
Q4 24
$33.6M
Q3 24
$42.3M
Q2 24
$37.4M
FCF Margin
DGICA
DGICA
RGEN
RGEN
Q1 26
Q4 25
8.9%
Q3 25
23.0%
Q2 25
11.8%
Q1 25
6.8%
Q4 24
19.3%
Q3 24
27.3%
Q2 24
24.3%
Capex Intensity
DGICA
DGICA
RGEN
RGEN
Q1 26
Q4 25
4.1%
Q3 25
2.5%
Q2 25
3.9%
Q1 25
2.1%
Q4 24
3.2%
Q3 24
4.5%
Q2 24
3.1%
Cash Conversion
DGICA
DGICA
RGEN
RGEN
Q1 26
Q4 25
4.08×
1.93×
Q3 25
1.11×
3.23×
Q2 25
0.72×
1.92×
Q1 25
1.02×
2.57×
Q4 24
2.81×
Q3 24
0.76×
Q2 24
5.22×
12.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons